Allowable limits of performance' for external quality assurance programs - An approach to application of the stockholm criteria by the RCPA quality assurance programs

Clinical Biochemist Reviews

Volumn 33, Issue 4, 2012, Pages 133-139

  Jones, Graham R D ^a,b   Sikaris, Kenneth ^c,d   Gill, Janice ^e  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MELBOURNE PATHOLOGY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e RCPA Quality Assurance Programs Pty Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872420981     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Panteghini M. Implementation of standardization in clinical practice: not always an easy task. Clin Chem Lab Med 2012;50:1237-41.
2. Bowyer RC, Geary TD, Penberthy LA, Thomas DW. An Australian quality control scheme for clinical chemistry. The Clinical Biochemist Newsletter, March, 1981.
3. Ricos C, Baadenhuijsen H, Libeer CJ, Hyltoft Petersen P, Stockl D, Thienpont L, et al. External quality assessment: currently used criteria for evaluating performance in European countries, and criteria for future harmonization. Eur J Clin Chem Clin Biochem 1996;34:159-65.
4. Clinical Laboratory Improvement Act 2004. Part 493 Laboratory Requirements. Subpart I--Proficiency Testing Programs for Nonwaived Testing. http://wwwn.cdc.gov/clia/regs/subpart_i.aspx#493.929 (Accessed 17 September 2012).
5. RiliBÄK (Richtlinien der Bundesärztekammer). Richtlinie der Bundesärztekammer zur Qualitäts-sicherung laboratoriumsmedizinischer Unter -suchungen. http://www.bundesaerztekammer.de/downloads/RiliBAEKLabor201205.pdf (Accessed 17 Sep-tember 2012).
6. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
7. Miller WG, Jones GRD, Horowitz GL, Weycamp C. Proficiency Testing/External Quality Assessment: Current Challenges and Future Directions. Clin Chem 2011;57:1670-80.
8. Fraser CG, Kallner A, Kenny D, Hyltoft-Petersen P. Introduction: strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:477-8.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
10. Skeie S, Perich C, Ricos C, Araczki A, Horvath AR, Oosterhuis WP, et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem 2005;51:1145-53.
11. CDC Cholesterol Reference Method Laboratory Network. Clinical Laboratory Certification Program. http://www.cdc.gov/labstandards/crmln_clinical.html#Protocol (Accessed 17 September 2012).
12. Ricos C. Desirable Specifications for Total Error, Imprecision, and Bias, derived from intra- and inter-individual biologic variation. Westgard QC. http://www.westgard.com/biodatabase1.htm (Accessed 17 September 2012).
13. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001.
14. Sciacovelli L, Zardo L, Secchiero S, Plebani M. Quality specifications in EQA schemes: from theory to practice. Clin Chim Acta 2004;346:87-97.
15. Sciacovelli L, Secchiero S, Zardo L, Plebani M. External Quality Assessment Schemes: need for recognised requirements. Clin Chim Acta 2001;309:183-99.
16. Scherrer F, Boisson RC, Cartier R, Cohen R, Eynard JC, Poggi B, et al. About the choice of acceptability limits in external quality assessment schemes. Ann Biol Clin 2007;65:677-84